394% Biggest gainer of the day $ONVOPerfect dip buy with minimum risk before the pop back to highs for easy money 🎯 All that while the rest of the market ends the day in deep red +17.0% realized profit on the day while NASDAQ:TSLA NASDAQ:AAPL NASDAQ:NVDA NASDAQ:PLTR and the rest of the market all 🔻by ProfitTradeRoom2
$ONVO potential repeat pattern-I am watching the current price action closely for a major breakout -I like the high volume move higher on May 28th followed by a month long tight consolidation -I am seeing the high growth/most speculative stocks gain momentum (I believe $ONVO fits into that category) $ONV0 finviz.comLongby ETrades13
Organovo Magic ShowChart painting from the early 21st century, artist Maxi Scalibusa. No investment advice or a recommendation to buy or sell any securities. This is entertainment. Start 11.40 USDLongby Maxi-Scalibusa111
$ONVOMassive inverse head and shoulders formed, symmetrical triangle on right shoulder expecting it to break above long term target is $29 (ark also has a small position)Longby Mike_yUpdated 444
ONVO: Bullish BATONVO Please don't forget to FOLLOW, LIKE, and COMMENT ... If you like my analysis:) Thank you and Good Luck!Longby KlejdiCuniUpdated 141420
$ONVO - A little known Biotech Innovator with COVID TechnologiesMy first overview of a narrative driven trade that is likewise seeing strong bottoming in technicals. Let's start with the narrative and get all excited before we get into what actually matters, the only truth - price action. ONVO is a microcap. While I have found myself trading smallcaps/microcaps recently, I honestly did not think I would be writing about them publicly. We have seen increasing amounts of VERY sketchy trading going on in microcaps (ehheeeemmmm $KODK...) and I in no way want a part of this; rather, I want to invest/trade in something that has a strong fundamental/narrative basis and/or technicals that make me want to go long/short. With that said, ONVO is a biotech; taken from wikipedia "Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue (also known as 3D bioprinting technology) for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting." - en.wikipedia.org Also from the same wikipedia page (why paraphrase when I can quote?) "The company bioprints and markets human tissues as a means of accelerating the preclinical drug testing and discovery process, enabling treatments to be created more quickly and at lower cost, and without immediate risks to living test subjects. Organovo has long-term expectations that this technology could be suitable for surgical therapy and transplantation" Ok. One of a couple billion biotechs with no revenue and a promising technology. Meh. But here's what catches my eye and makes me add it... COVID-19. Yes, ONVO is one of a couple million (hey - not billion!) biotechs with COVID-19 technologies. I am a trader and investor. I am not a biotech analyst. In fact, not only am I not a biotech analyst but I am frankly dumb-money here. As a trader, I've been buying virtually anything with COVID exposure as part of my COVID basket of stocks and frankly that's been working. Maybe a bit too simple & stupid for biotech traders but has been working for now and looking for this to continue over the next few months at which point I'll likely re-consider this trade. NYT article on 3D tissue printing and COVID: www.nytimes.com When that article printed the stock went up about 15%, and then pulled back. While I'm still laying out non-technical points, my final point is ARK's position in ONVO: ark-funds.com ARK has ONVO weighted at .18% of its top portfolio ARKK; however, due to the size of ARKK ARK actually owns 20% of the company. While I am dumb money fundamentally in biotechs, ARK is not in my view. So this is partially me putting ONVO in my COVID basket and partially following ARK. Ok let's get to the fun stuff, the technicals. ONVO appears to be in the first wave after a 5 wave downtrend. Elliott wave is up for debate for me but I find it useful occasionally - if nothing else it's simply another data point I can use. In addition to a potential flip in general direction we are seeing what appears to be a textbook bullish Butterly at the bottom, indicating a technical reversal. Now I am no Elliott wave expert and CERTAINLY no Butterfly expert but it doesn't take a genius to see the pattern as it bottoms below $1. Butterfly is typically used in forex trading which is why I am so hesitant to include it here. If you regularly use Butterfly to trade forex and you've come across this post PLEASE comment your thoughts/views as to my Butterfly theory here. Would love to be shredded to pieces by an experienced forex trader calling my Butterfly anything but a Butterfly. Finally, the potential for this to catch momentum on it being involved in COVID drug discovery seems huge with the mix of technical and narrative. I am long ONVO shares here and looking to double my position if we get it at the 'D' point in Butterfly - the typical long entry for Butterfly reversal.Longby UnknownUnicorn7308096Updated 117
Oraganovo Holdings Long-term LongSpeculative medium to high risk addition. organovo.comby UnknownUnicorn84746146
ONVO - Bullish Move Inbound? Breakout LikelyOrganovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA. SHORT INTEREST 5.65M 09/13/19 P/E Current -1.21 P/E Ratio (with extraordinary items) -1.39 Average Recommendation: HOLD Average Target Price: 1.50Longby DEXWireNews12
Organovo Collaborates With MCRI and Leiden UniversityOrganovo Holdings (NASDAQ:ONVO) collaborates with Professor Melissa Little at the Murdoch Children's Research Institute (“MCRI”), The Royal Children’s Hospital, Melbourne, Australia and Ton Rabelink at Universiteit Leiden (“LUMC”), Leiden, Netherlands. The project will expand the use of 3D bioprinted stem cell-based therapeutic tissues aimed at treating end-stage renal disease. The collaboration is being funded by Stem Cells Australia and CSL Limited. finance.yahoo.comby AlenCiken0
long at 1.01target 2.22 - all bets off if they attack/ break the current share structureLongby noam_chomUpdated 112
ONVO Uptrend pendingThis could be a start of an uptrend if not I see ONVO slowly retrace to .90 Longby jbevans02223
Organovo Holding INC | $ONVO | SHORTEntry Short Signal at $1.74 Cover at $1.64 Profits $305Shortby SignalsFinancial0
Organovo Long OpportunityBig bullish divergence in terms of volume and price, with a spike up in volume and a downwards trend in price with lower highs, we are in the accumulation phase before we will see a big spike in the next 10 days. Profit targets around the $2 level makes this a great day trade or potential investment with a tight stop below the lower support levels. Bullish trend located in the higher highs on RSI and downward trend in price.Longby trader21773211
Clear rejection of previous low.ONVO some small downside potential.Shortby ErikTheMarketMakerUpdated 4